Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin added to antibiotics for suspected ventilator-associated pneumonia
2008-002019-42Phase 3Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of simvastatin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: 28-day mortality after randomization. Started May 2009; status: active.
02
Drugs
simvastatin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2008-002019-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002019-42.